Cost-effectiveness of increasing vaccination in high-risk adults aged 18–64 Years: a model-based decision analysis

Improving adolescent HPV vaccination in a randomized controlled cluster trial using the 4 Pillars™ practice Transformation Program

(2017) Richard K. Zimmerman et al.   VACCINE

Using a Mixed Methods Approach to Examine Practice Characteristics Associated With Implementation of an Adult Immunization Intervention Using the 4 Pillars Practice Transformation Program

(2017) Mary Hawk et al.   Journal for Healthcare Quality

Maintenance of Increased Childhood Influenza Vaccination Rates 1 Year After an Intervention in Primary Care Practices

(2016) Mary Patricia Nowalk et al.   Academic Pediatrics

Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial

(2016) Chyongchiou J. Lin et al.   BMC INFECTIOUS DISEASES

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses

(2016) Gillian D. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

(2016) Charles Stoecker et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Cost-Effectiveness of the 4 Pillars Practice Transformation Program to Improve Vaccination of Adults Aged 65 and Older

(2016) Kenneth J. Smith et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Using the 4 Pillars Practice Transformation Program to Increase Pneumococcal Immunizations for Older Adults: A Cluster-Randomized Trial

(2016) Richard K. Zimmerman et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial

(2016) Mary Patricia Nowalk et al.   VACCINE

The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010

(2015) Cristina Masseria et al.   BMC INFECTIOUS DISEASES

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

(2015) Matthew R Moore et al.   LANCET INFECTIOUS DISEASES

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

(2015) Marc J.M. Bonten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States

(2014) Constantinos I Michaelidis et al.   BMC PUBLIC HEALTH

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) for Preventing Pertussis: Evidence of Rapidly Waning Immunity and Difference in Effectiveness by Tdap Brand

(2014) Ruth Koepke et al.   JOURNAL OF INFECTIOUS DISEASES

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission

(2014) Lisa J. McGarry et al.   PLoS One

Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care

(2014) Richard K. Zimmerman et al.   VACCINE

Cost-Effectiveness of a Program to Eliminate Disparities in Pneumococcal Vaccination Rates in Elderly Minority Populations: An Exploratory Analysis

(2013) Constantinos I. Michaelidis et al.   VALUE IN HEALTH

Success of the 4 Pillars Toolkit for Influenza and Pneumococcal Vaccination in Adults

(2013) Mary Patricia Nowalk et al.   Journal for Healthcare Quality

Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine

(2012) Kenneth J. Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years

(2012) Derek Weycker et al.   VACCINE

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Estimating the cost-effectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups

(2011) Constantinos I. Michaelidis et al.   VACCINE

Prevalence of high-risk indications for influenza vaccine varies by age, race, and income

(2010) Richard K. Zimmerman et al.   VACCINE